ArticleJAMIA open2026
Build fair machine learning models to predict adverse outcomes for heart failure patients with preserved ejection fraction and with reduced ejection fraction.
Article in JAMIA open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Develop and validate subtype-specific, fairness-aware machine learning (ML) models that integrate clinical and social determinants of health (SDoH) information to predict 6-month readmission or mortality after hospitalization among patients with HFpEF or HFrEF, and to evaluate the incremental contribution of SDoH, model explainability, and subgroup error disparities across demographic groups. Materials and Methods: We used University of Florida Health electronic health record (EHR) data (2016-2022) to identify adult heart failure (HF) hospitalizations and followed patients for 6 months for a composite outcome of readmission or mortality. Features included clinical characteristics, contextual SDoH (eg, neighborhood deprivation), and individual SDoH extracted from clinical notes via natural language processing (NLP). Logistic regression and XGBoost models were trained with random oversampling. Performance metrics included the C statistic, F1-score, and recall. Fairness was evaluated using false negative rate (FNR) parity across sex, race/ethnicity, and age band, and mitigation methods were applied (eg, Disparate Impact Remover, Adversarial Debiasing, and Calibrated Equalized Odds). Results: Adding SDoH improved the C statistic for logistic regression in HFpEF (0.603 vs 0.586) and HFrEF (0.641 vs 0.637). SHapley Additive exPlanations (SHAP) highlighted sodium, financial constraint level, and emergency department visit count in HFpEF, and utilization measures and financial constraint level in HFrEF. FNR ratios indicated race/ethnicity disparities; HFpEF FNRBlack/FNRWhite was 0.7834 (0.8728 after Disparate Impact Remover), and HFrEF FNRHispanic/FNRWhite was 1.2217 (0.9880 after Adversarial Debiasing). Discussion: SDoH integration and mitigation can modestly improve performance while reducing subgroup error disparities. Conclusion: Subtype-specific, fairness-aware ML models for HFpEF and HFrEF provided interpretable 6-month risk stratification and enabled subgroup fairness assessment. Integrating clinical and SDoH information added modest discrimination gains while strengthening interpretation and fairness assessment. These findings support further validation of explainable, equity-aware HF prediction models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.